Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori

Condition:   Helicobacter Pylori Infection Intervention:   Drug: Tegoprazan Sponsor:   Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials